Career Enhancement Program
职业提升计划
基本信息
- 批准号:10226976
- 负责人:
- 金额:$ 8.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-24 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AreaBasic ScienceCancer BiologyClinicalDevelopmentDisciplineDiseaseEnvironmentExhibitsFacultyGeneticGoalsImmunologyIndividualInstitutionInvestigational TherapiesMalignant NeoplasmsMalignant neoplasm of urinary bladderMedical InformaticsMemorial Sloan-Kettering Cancer CenterMentorsMolecular BiologyOncologyOperative Surgical ProceduresOutcomes ResearchPathologyPelvisPlayPositioning AttributePublic HealthRenal carcinomaResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesScheduleScientistTalentsTherapeuticTrainingTranslatingTranslational ResearchUnderrepresented PopulationsUnited StatesUreter CarcinomaUrotheliumWomananticancer researchbladder Carcinomacareerclinically relevantdesigninter-institutionalinterestprogramsracial and ethnicrecruitsymposiumtumor
项目摘要
PROJECT SUMMARY/ABSTRACT
The Career Enhancement Program (CEP) of the SPORE in Bladder Cancer at Memorial Sloan Kettering
Cancer Center (MSK) will prepare the most promising and motivated young clinician-scientists for independent
careers as investigators in translational research in urothelial cancer. Eligible candidates will include junior
faculty with a demonstrated interest in urothelial cancer research, advanced postdoctoral clinical fellows who
exhibit outstanding research potential in urothelial cancer and are ready to transition to a faculty position within
1 year, and established investigators who wish to enhance or refocus their careers on translational research in
urothelial cancer. We have designed the CEP to form both an interdepartmental and an inter-institutional
training ground in which to nurture 2 talented new investigators each year—from either basic research or
clinical backgrounds—committed to translating new scientific developments in urothelial cancer research into
clinically relevant therapeutic strategies. By combining the research and academic resources available
throughout MSK and at our affiliated institutions, CEP recipients will benefit from the intersection of a
comprehensive educational program, career enrichment activities, and a rich research environment cultivated
by the senior investigators in the SPORE in Bladder Cancer. The diverse research areas in our proposed
SPORE in Bladder Cancer pursue research questions at every stage of the disease. Opportunities with
SPORE investigators as mentors include disciplines such as oncology, surgery, pathology, immunology,
molecular biology, cancer biology, tumor and germline genetics, experimental therapeutics, medical
informatics, and outcomes research. The CEP and MSK are committed to recruiting women and individuals
from racial/ethnic groups that are underrepresented in oncology.
项目总结/摘要
斯隆-凯特琳纪念医院膀胱癌专业研究院的职业提升计划(CEP)
癌症中心(MSK)将准备最有前途和积极的年轻临床科学家独立
作为尿路上皮癌转化研究的研究者。合格的候选人将包括初级
在尿路上皮癌研究表现出兴趣的教师,先进的博士后临床研究员谁
在尿路上皮癌表现出杰出的研究潜力,并准备过渡到一个教师的位置内
1年,并且希望在以下领域加强或重新关注其职业生涯的研究人员:
尿路上皮癌我们设计了CEP,以形成一个跨部门和跨机构的
培训基地,每年培养2名有才华的新研究人员,无论是基础研究还是
临床背景-致力于将尿路上皮癌研究的新科学发展转化为
临床相关的治疗策略。通过结合现有的研究和学术资源
在整个MSK和我们的附属机构,CEP受助人将受益于一个交叉点,
全面的教育计划,职业丰富的活动,和丰富的研究环境培养
由膀胱癌SPORE的高级研究人员进行。我们建议的不同研究领域
膀胱癌的孢子追求在疾病的每个阶段的研究问题。机会与
作为导师的SPORE研究人员包括肿瘤学、外科学、病理学、免疫学、
分子生物学、癌症生物学、肿瘤和生殖系遗传学、实验治疗学、医学
信息学和成果研究。CEP和MSK致力于招募女性和个人
来自肿瘤学代表性不足的种族/民族群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean F. Bajorin其他文献
428: Clinical Outcome of Intermediate- and Poor-Risk Patients with Non-Seminomatous Germ Cell Testicular Cancer (NSGCT) Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND)
- DOI:
10.1016/s0022-5347(18)34681-0 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Bobby Shayegan;Brett S. Carver;Andrew J. Stephenson;Dean F. Bajorin;Robert J. Motzer;George J. Basl;Joel Sheinfeld - 通讯作者:
Joel Sheinfeld
930: Clinical Outcome and Postoperative Chemotherapy Requirement in Patients with Clinical Stage IIA and IIB Non-Seminomatous Germ Cell Tumor (NSGCT) Following Primary Retroperitoneal Lymph Node Dissection: Impact of Preoperative Serum Tumor Markers (STM)
- DOI:
10.1016/s0022-5347(18)38179-5 - 发表时间:
2004-04-01 - 期刊:
- 影响因子:
- 作者:
Joel Sheinfeld;Andrew J. Stephenson;Robert J. Motzer;Dean F. Bajorin;George J. Bosl - 通讯作者:
George J. Bosl
429: Postchemotherapy Retroperitoneal Lymph Node Dissection for Patients with Elevated Tumor Serum Markers
- DOI:
10.1016/s0022-5347(18)34682-2 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Zohar A. Dotan;Fernando J. Bianco;Jason P. Stasi;Robert J. Motzer;Dean F. Bajorin;George J. Bosl;Joel Sheinfeld - 通讯作者:
Joel Sheinfeld
MP77-20 FGFR3 MUTATION ASSOCIATES WITH IMPROVED CANCER SPECIFIC OUTCOME IN UPPER TRACT UROTHELIAL CARCINOMA
- DOI:
10.1016/j.juro.2014.02.2483 - 发表时间:
2014-04-01 - 期刊:
- 影响因子:
- 作者:
John P. Sfakianos;Eugene K. cha;Philip H. kim;Gopa Iyer;A.A. Hakimi;Sasinya N. Scott;Ricardo Ramirez;Aphrothiti J. Hanrahan;Jonathan E. Rosenberg;Qinghu Ren;Hikmat Al-Ahmadie;Guido Dalbagni;Dean F. Bajorin;Michael F. Berger;Bernard H. Bochner;David B. Solit;Jonathan A. Coleman - 通讯作者:
Jonathan A. Coleman
Molecular, immunohistochemical and morphologic analysis of urothelial carcinoma with ERBB2/ERBB3 mutations
- DOI:
10.1097/01.pat.0000454567.82822.1a - 发表时间:
2014-01-01 - 期刊:
- 影响因子:
- 作者:
Qinghu Ren;Philip H. Kim;John P. Sfakianos;Eugene K. Cha;Sasinya Scott;Gopakumar Iyer;Anupama Gandhi;Aphrothiti J. Hanrahan;Satish K. Tickoo;Samson W. Fine;Anuradha Gopalan;Ying-Bei Chen;Jonathan E. Rosenberg;Dean F. Bajorin;Bernard H. Bochner;Victor E. Reuter;Michael F. Berger;David B. Solit;Hikmat A. Al-Ahmadie - 通讯作者:
Hikmat A. Al-Ahmadie
Dean F. Bajorin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean F. Bajorin', 18)}}的其他基金
RP-2: Discovery and Characterization of Novel Genes and DNA Repair Pathways Predisposing to Urothelial Cancer
RP-2:易患尿路上皮癌的新基因和 DNA 修复途径的发现和表征
- 批准号:
10453634 - 财政年份:2018
- 资助金额:
$ 8.24万 - 项目类别:
RP-2: Discovery and Characterization of Novel Genes and DNA Repair Pathways Predisposing to Urothelial Cancer
RP-2:易患尿路上皮癌的新基因和 DNA 修复途径的发现和表征
- 批准号:
9979819 - 财政年份:2018
- 资助金额:
$ 8.24万 - 项目类别:
相似海外基金
HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
- 批准号:
2318404 - 财政年份:2023
- 资助金额:
$ 8.24万 - 项目类别:
Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 8.24万 - 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 8.24万 - 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
- 批准号:
480914 - 财政年份:2023
- 资助金额:
$ 8.24万 - 项目类别:
Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 8.24万 - 项目类别:
Australian Laureate Fellowships
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
- 批准号:
22K02974 - 财政年份:2022
- 资助金额:
$ 8.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 8.24万 - 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
- 批准号:
10431468 - 财政年份:2022
- 资助金额:
$ 8.24万 - 项目类别:














{{item.name}}会员




